Search by Drug Name or NDC

    NDC 70842-0101-01 Baxdela 450 mg/1 Details

    Baxdela 450 mg/1

    Baxdela is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Melinta Therapeutics, LLC. The primary component is DELAFLOXACIN MEGLUMINE.

    Product Information

    NDC 70842-0101
    Product ID 70842-101_3005a09f-04c1-42d2-85c9-3ed861e26c2e
    Associated GPIs 05000025100320
    GCN Sequence Number 077492
    GCN Sequence Number Description delafloxacin meglumine TABLET 450 MG ORAL
    HIC3 W1Q
    HIC3 Description QUINOLONE ANTIBIOTICS
    GCN 43532
    HICL Sequence Number 044372
    HICL Sequence Number Description DELAFLOXACIN MEGLUMINE
    Brand/Generic Brand
    Proprietary Name Baxdela
    Proprietary Name Suffix n/a
    Non-Proprietary Name delafloxacin meglumine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 450
    Active Ingredient Units mg/1
    Substance Name DELAFLOXACIN MEGLUMINE
    Labeler Name Melinta Therapeutics, LLC
    Pharmaceutical Class Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208610
    Listing Certified Through 2024-12-31

    Package

    NDC 70842-0101-01 (70842010101)

    NDC Package Code 70842-101-01
    Billing NDC 70842010101
    Package 1 BOTTLE in 1 CARTON (70842-101-01) / 20 TABLET in 1 BOTTLE
    Marketing Start Date 2017-06-19
    NDC Exclude Flag N
    Pricing Information N/A